Mr. George L. Sing is a Co-Founder and Managing Director at Lancet Capital since 1998. Mr. Sing was Co-Founder of Stemnion, Inc. (currently known as Noveome Biotherapeutics, Inc.) and served as its Chief Executive Officer from January 2004 to April 2015. He has extensive healthcare and financial expertise as a healthcare venture capital investor and biomedical company chief executive officer and has executive leadership experience. From 1993 to 1998, he was a General Partner at Zitan Capital Partners. He was also a co-founding Senior Partner of two other venture capital firms, Advanced Technology Ventures and Merrill Lynch Ventures, where he pioneered initial investments in European and Asian venture funds. From February 1990 until February 1991, Mr. Sing served as a Consultant at Merrill Lynch Venture Capital Inc. From 1982 to February 1990, he served as a Vice President and Member of the Board of Directors of Merrill Lynch Venture Capital, Inc. He serves as a Director of Lancet Capital. He has been a Director at Regeneron Pharmaceuticals since January 01, 1988. Mr. Sing has been a venture capital investor for over 20 years, including co-founding seed stage startups in healthcare and high technology. He received Master of Business Administration degree from Harvard Business School and Bachelor of Engineering degree from Stevens Institute of Technology.